These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24582686)

  • 1. The ideal blood pressure target to prevent cardiovascular disease in type 2 diabetes: a neutral viewpoint.
    Frontoni S; Solini A; Fioretto P; Natali A; Zuccalà A; Cosentino F; Penno G;
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):577-84. PubMed ID: 24582686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between the risk of cardiovascular disease in type 2 diabetes patients and both visit-to-visit variability and time-to-effect differences in blood pressure.
    Takao T; Kimura K; Suka M; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
    J Diabetes Complications; 2015 Jul; 29(5):699-706. PubMed ID: 25861721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How early should blood pressure control be achieved for optimal cardiovascular outcomes?
    Weir MR; Zappe D; Orloski LA; Sowers JR
    J Hum Hypertens; 2011 Apr; 25(4):211-7. PubMed ID: 20596060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: established knowledge and evidence gaps.
    Paneni F
    Diab Vasc Dis Res; 2014 Jan; 11(1):5-10. PubMed ID: 24254974
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of hypertension in diabetic patients: outstanding issues.
    Camafort-Babkowski M; Barrios V; Coca A
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):721-8. PubMed ID: 21714603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of blood pressure control in the patient with diabetes.
    Bakris GL
    Am J Med; 2004 Mar; 116 Suppl 5A():30S-38S. PubMed ID: 15019861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What should be the optimal levels of blood pressure: Does the J-curve phenomenon really exist?
    Banach M; Michalska M; Kjeldsen SE; Małyszko J; Mikhailidis DP; Rysz J
    Expert Opin Pharmacother; 2011 Aug; 12(12):1835-44. PubMed ID: 21517698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Success of blood pressure reduction in diabetic patients].
    Schernthaner G
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S247-51. PubMed ID: 17139580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential implications of the choice among three alternative treatment targets for apolipoprotein B100 in the management of patients with type 2 diabetes and chronic kidney disease.
    Boronat M; García-Cantón C; López-Ríos L; Quevedo V; Lorenzo DL; Batista F; Riaño M; Nóvoa FJ
    Diab Vasc Dis Res; 2014 Jan; 11(1):53-9. PubMed ID: 24254975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of treatment principles of elderly hypertensive patients with different cardiovascular risks based on Hungarian and international guidelines (2001-2015)].
    Bödör A; Kiss I
    Orv Hetil; 2016 Feb; 157(7):247-59. PubMed ID: 26853726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Pressure Management in Patients with Type 2 Diabetes.
    Eguchi K
    Intern Med; 2015; 54(18):2285-9. PubMed ID: 26370850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM).
    Basile JN
    J Diabetes Complications; 2013; 27(3):280-6. PubMed ID: 23375850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.
    Bangalore S; Kumar S; Lobach I; Messerli FH
    Circulation; 2011 Jun; 123(24):2799-810, 9 p following 810. PubMed ID: 21632497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Am J Hypertens; 2012 Mar; 25(3):325-34. PubMed ID: 22158066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of ACCORDIAN in ACCORD with lower blood pressure begetting lower mortality in patients with diabetes.
    Laffin LJ; Bakris GL
    Diabetes Obes Metab; 2018 Jun; 20(6):1335-1336. PubMed ID: 29424470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lifestyle intervention in patients with type 2 diabetes: a meta-analysis.
    Chen L; Pei JH; Kuang J; Chen HM; Chen Z; Li ZW; Yang HZ
    Metabolism; 2015 Feb; 64(2):338-47. PubMed ID: 25467842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.